Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

3D-Printed hip implant could replace risky surgery

NCT ID NCT07072832

Disease control Sponsor: Replasia BV Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times

Summary

This study tests a new 3D-printed implant for adults with hip dysplasia, a condition where the hip socket doesn't fully cover the thigh bone, causing pain and gait problems. Ten participants aged 18-45 will receive the implant to see if it is safe and helps improve hip function and recovery. The goal is to offer a less invasive option with fewer complications than the current standard surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hip dysplasia based on AP x-ray with a LCEA of \<25° * Groin pain and/or gait abnormalities, with no other explanatory hip pathology * Aged at least 18 years and maximal 45 years at time of surgery (indicated age for PAO(19)) * Willing to comply with the study visit schedule during 12 month follow-up * Able and willing to provide informed consent Exclusion Criteria: * Previous acetabular surgery \>10yr of age * Signs of osteoarthritis on x-ray (Tonnis classification \>1), * Body mass index of more than 35 * Large labral tears visible on non-contrast MRI * Pre-consultation known titanium allergy * Pre-consultation known medical histories of diseases that per the investigator possibly affect the outcome: neuromuscular disease affecting the stability of the hip, diseases affecting bone ingrowth and fixation strength of the implant like rheumatoid arthritis and metabolic bone diseases, e.g. osteomalacie, osteoporosis, hyperparathyroidism, hypercalcemia. * Pre-consultation known pregnant women or women who are planning to become pregnant during the duration of the study. * Part of vulnerable population (e.g. Mentally disabled with cognitive impairment or mental disease) * Currently participating in another investigational clinical trial. * Unable to provide informed consent (e.g. insufficient language skills)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip dysplasia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

developmental dysplasia of the hip Hip Dislocation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip dysplasia

Contacts and locations

Locations

  • Anna Ziekenhuis

    Geldrop, 5664 BE, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.